Active Ingredient Ipilimumab

Active Ingredient Details

What is Ipilimumab?

An anti-CTLA-4 ANTIGEN monoclonal antibody initially indicated for the treatment of certain types of metastatic MELANOMA. Its mode of actions may include blocking of CTLA-4 mediated inhibition of CYTOTOXIC T LYMPHOCYTES, allowing for more efficient destruction of target tumor cells.

What is the usage for Ipilimumab?

Ipilimumab is used to treat various cancers (such as skin, kidney, liver, lung, colorectal). Ipilimumab belongs to a class of drugs known as monoclonal antibodies. It works by slowing or stopping the growth of cancer cells. However, it can have serious side effects in other parts of your body (see also Side Effects section).

How many products in the NDC database contain Ipilimumab?

The NDC database has 7 products with the active ingredient Ipilimumab. The following table lists all the products that have this active ingredient.

NDC Products with Ipilimumab

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0003-2327Proprietary Name: Yervoy IpilimumabInjectionIntravenousE.r. Squibb & Sons, L.l.c.ACTIVE
0003-2328Proprietary Name: Yervoy IpilimumabInjectionIntravenousE.r. Squibb & Sons, L.l.c.ACTIVE
71124-0001Proprietary Name: IpilimumabLiquidSamsung Biologics Co., Ltd.ACTIVE
71124-0020Proprietary Name: IpilimumabSolutionSamsung Biologics Co. LtdACTIVE
71124-0021Proprietary Name: IpilimumabSolutionSamsung Biologics Co. LtdACTIVE
71124-0022Proprietary Name: IpilimumabSolutionSamsung Biologics Co., Ltd.ACTIVE
83157-2327Proprietary Name: IpilimumabInjectionLotte Biologics Usa, LlcACTIVE
<